Sheng-Shou Hu;Writing Committee of the Report on Cardiovascular Health and Diseases in China
Sheng-Shou Hu;Writing Committee of the Report on Cardiovascular Health and Diseases in China
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this eighth section of the report offers a comprehensive analysis of pul...
Alcohol drinking triggered decrease of oxidative balance score is associated with high all-cause and cardiovascular mortality in hypertensive individuals: findings from NHANES 1999-2014 [0.03%]
饮酒诱发的氧化平衡分下降与高血压人群全因及心血管死亡高风险有关：来自1999-2014年NHANES调查结果
Yu-Jun Zhang,Jing-Jing Song,Jian-Hao Zhan et al.
Yu-Jun Zhang et al.
Background: Oxidative stress is closely associated with hypertensive outcomes. The oxidative balance score (OBS) measures oxidative stress exposure from dietary and lifestyle elements. The objective of this study was to i...
Lipid-lowering effects of gefarnate in statin-treated patients with residual hypertriglyceridemia: a randomized controlled study [0.03%]
吉法贝治疗他汀类药物治疗后仍存在高甘油三酯血症患者的降脂疗效：一项随机对照研究
Jing Shi,Ming-Lu Xu,Mei-Jiao He et al.
Jing Shi et al.
Background: The prevention of coronary artery disease (CAD) faces dual challenges: the aspirin-induced gastrointestinal injury, and the residual cardiovascular risk after statin treatment. Geraniol acetate (Gefarnate) is ...
Healthy life expectancy with cardiovascular disease among Chinese rural population based on the prospective cohort study [0.03%]
基于前瞻性队列研究的中国农村心血管病患者健康预期寿命分析
Feng Jiang,Xiao-Tian Liu,Ze Hu et al.
Feng Jiang et al.
Background: Limited research has explored the impact of cardiovascular disease (CVD) on healthy life expectancy (HLE) especially in resource-limited areas. This study aimed to investigate the association between CVD and H...
Shing Ching,Chiu Sun Yue
Shing Ching
Narrative review of latest research progress about robotic percutaneous coronary intervention [0.03%]
机器人经皮冠状动脉介入治疗最新研究进展叙事性回顾
Zhen-Yu Liu,Guang-Yao Zhai
Zhen-Yu Liu
Robotic percutaneous coronary intervention (R-PCI) is a novel technology in which operators can manipulate guidewires and catheter devices in interventional cardiology. This approach provides great benefits to interventional cardiologists i...
Optimal timing of invasive intervention for high-risk non-ST-segment-elevation myocardial infarction patients [0.03%]
高危非ST段抬高型心肌梗死患者侵入性干预的适宜时机
Juan-Juan Zheng,Yue-Qiao Si,Tian-Yang Xia et al.
Juan-Juan Zheng et al.
Objective: To compare the immediate, early, and delayed percutaneous coronary intervention (PCI) strategies in non-ST-segment-elevation myocardial infarction (NSTEMI) patients with high-risk. ...
Sheng-Shou Hu
Sheng-Shou Hu
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this seventh section of the report offers a comprehensive analysis of di...
The impact of being in the COVID-19 pandemic on in-hospital mortality of non-infected patients aged 80 years and older with ST-elevation myocardial ınfarction [0.03%]
COVID-19大流行对非感染的80岁及以上老年ST段抬高型心肌梗死患者住院死亡率的影响
Mustafa Ebik,Muhammet Gürdoğan,Uğur Özkan
Mustafa Ebik
Consensus on glycemic management for patients with coronary heart disease and type 2 diabetes [0.03%]
冠心病合并2型糖尿病患者血糖管理的专家共识
Cardiovascular Subcommittee of Chinese International Exchange and Promotion Association for Medical and Healthcare;Li-Nong Ji,Yun-Dai Chen
Cardiovascular Subcommittee of Chinese International Exchange and Promotion Association for Medical and Healthcare;Li-Nong Ji
The prevalence of patients with coronary heart disease (CHD) and diabetes mellitus is notably high, posing significant residual cardiovascular risks even after routine interventions such as antihypertensive, lipid-lowering, and antithrombot...